Rama Padmanabhan

Partner
Full contact info

Experience

Inmagene Biopharmaceuticals Announces Merger With Ikena Oncology

December 23, 2024

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Asa Henin
Partner, San Diego
Matthew D. Silverman
Special Counsel, Santa Monica
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Jiqiang Lin
Associate, New York
Leina Verrier
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jean Park
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michelle Garcia Schulman
Partner, Reston
Ellie Seber
Partner, Santa Monica
Marty Schenker
Senior Counsel , San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Special Counsel, Brussels
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Ajay Athavale
Associate, San Francisco
Rajdeep Roger Bains
Associate, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Adrienne Beaudoin Deshmukh
Associate, Reston
Jeremy M. Exelbert
Associate, New York
Daniel Gillon
Associate, San Diego
Zack Gong
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Wyatt Kernell
Associate, Colorado
Rebeca Kinslow
Associate, San Diego
Hilda Li
Associate, Hong Kong
Lunga Su
Associate, Shanghai
Novak Topalovic
Associate, San Diego
Tania Soris
Associate, New York
Christine Tse
Associate, New York
Monica Xu
Special Counsel, Shanghai
Sai Yarramalla
Associate, Palo Alto
Andy Zachrich
Associate, San Diego
Zheng Zhou
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Chimagen Biosciences Announces Sale of CMG1A46 to GSK

October 29, 2024

Cooley advised Chimagen Biosciences, a privately held biotechnology company, on its agreement to sell CMG1A46, a clinical-stage dual CD19 and CD20-targeted T-cell engager (TCE), to GSK, a global biopharma company, for an upfront payment of $300 million, plus success-based development and commercial milestone payments totaling up to $550 million.

Read more

Related contacts

Marya Postner
Partner, Palo Alto
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Zack Gong
Associate, Shanghai
Jenny Ge
Associate, Santa Monica
Monica Xu
Special Counsel, Shanghai
Natasha Kaye
Partner, London
Christopher Kimball
Partner, Washington, DC
Rama Padmanabhan
Partner, San Diego
Aaron Pomeroy
Partner, Colorado
Jonathan Rivinus
Partner, Colorado
Rachel Thorn
Partner, New York
David Wilson
Partner, London
David Burns
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Robert Eisenbach
Of Counsel, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Eerik Kukebal
Associate, London
Amanda Pacheco
Associate, Palo Alto
Leo Spicer-Phelps
Partner, London
Lunga Su
Associate, Shanghai
Ivy Wang
Associate, Shanghai
Zhijing Yu
Associate, Singapore
Letian Wei
Legal Consultant, Shanghai

Related Practices & Industries

Nerio Therapeutics Sells to Boehringer Ingelheim for up to $1.3 Billion

July 29, 2024

Cooley advised Nerio Therapeutics, a drug discovery and development company focused on phosphatases, a notoriously difficult class of potentially high-value therapeutic protein targets, on its sale to Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, for up to $1.3 billion.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Charity Williams
Partner, San Diego
Rajdeep Roger Bains
Associate, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Santa Monica
Lei Shen
Partner, Chicago
Allison Kutner
Associate, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Jeffrey J. Tolin
Partner, New York
Ross Eberly
Partner, Santa Monica
Dylan Kornbluth
Associate, San Diego
Joanna Zhang
Associate, San Diego
Allie Pilmer
Associate, San Diego
Howard Morse
Partner, Washington, DC
Ajay Athavale
Associate, San Francisco
Sharon Connaughton
Special Counsel, Washington, DC
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Radionetics Oncology Announces Strategic Agreement With Eli Lilly

July 1, 2024

Cooley advised Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein-coupled receptor (GPCR)-targeted radiopharmaceuticals to treat a broad range of solid tumors, on the formation of a strategic agreement with Eli Lilly to take forward Radionetics’ proprietary GPCR-targeting small molecule radiopharmaceuticals. Under the terms of the agreement, Radionetics received a $140 million up-front cash payment. Additionally, Lilly obtained the exclusive right to acquire Radionetics for $1 billion upon conclusion of an exercise period.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Charity Williams
Partner, San Diego
Jenny Ge
Associate, Santa Monica
Chen Chen
Associate, Palo Alto
Todd Gluth
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Howard Morse
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Ajay Athavale
Associate, San Francisco
Kyle Hess
Associate, New York
Jonathan Kaufman
Associate, Palo Alto
Allison Kutner
Associate, New York
Edmond Lay
Partner, San Diego
Jeremy Gentile
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Breanna Qin
Associate, Palo Alto
Megan Drill
Associate, San Diego
Daniel Gillon
Associate, San Diego
Jack Whitaker
Associate, San Diego
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

ProfoundBio Announces $1.8 Billion Acquisition by Genmab

April 3, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab (NASDAQ: GMAB), a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Rowook Park
Partner, San Diego
Ruomu Li
Partner, Shanghai
Jenny Ge
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Jamie Leigh
Partner, San Francisco
Izzy Lubarsky
Partner, New York
Barbara Mirza
Partner, Santa Monica
Sonia Nath
Partner, Washington, DC
Jean Park
Partner, New York
Lei Shen
Partner, Chicago
Stacey A. Bradford
Special Counsel, Washington, DC
Jeff Goldman
Special Counsel, Palo Alto
Amy Hallman Rice
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Andrew Bae
Associate, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Megan Drill
Associate, San Diego
Mari Dugas
Associate, Washington, DC
Allison Kutner
Associate, New York
Jiqiang Lin
Associate, New York
Tyler Saavedra-Buckley
Associate, San Francisco
Ivy Wang
Associate, Shanghai
Monica Xu
Special Counsel, Shanghai
Freddy Yip
Associate, Hong Kong
Zhijing Yu
Associate, Singapore
Andy Zachrich
Associate, San Diego
Letian Wei
Legal Consultant, Shanghai

Related Practices & Industries

View more

Admissions and credentials

California

Rankings and accolades

Chambers USA: Corporate/M&A – California: San Diego (2024)

Lawdragon: 500 Leading Dealmakers in America (2022, 2023)

The Deal: Middle Market Awards – Dealmaker of the Year in Healthcare, Pharma & Biotech (2020)

Memberships and affiliations

American Bar Association (ABA)